At the Bonferroni corrected significance threshold, we identified a protective effect of FGF21 and HACVR1 on T2D risk and a causal effect of HPGDS on decreased BMI (Fig. 7, Supplementary Data 6). Here, FGF21 is linked to type 2 diabetes mellitus.